1)Aoki R, Karube K, Sugita Y et al:Distribution of malignant lymphoma in Japan:Analysis of 2260 cases, 2001-2006. Pathology International 58:174-182, 2008
2)Sjö LD, Ralfkiaer E, Prause JU et al:Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest Ophthalmol Vis Sci 49:3283-3288, 2008
3)Ichimura K, Kagami Y, Suzuki R et al:Phenotypic analysis of peripheral T/NK cell lymphoma:study of 408 Japanese cases with special reference to their anatomical sites. Pathology International 53:333-334, 2003
4)Coupland SE, Foss HD, Assaf C et al:T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues:a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology 106:2109-2120, 1999
5)Hon C, Kwok AKH, Shek TWH et al:Vision-threatening complications of nasal T/NK lymphoma. Am J Ophthalmol 134:406-410, 2002
6)Kuwabara H, Tsuji M, Yoshii Y et al:Nasal-type NK/T lymphoma of the orbit with distant metastases. Hum Pathol 34:290-292, 2003
7)Shimonagano Y, Nakao K, Sakamoto T et al:Iris involvement in natural killer/T-cell lymphoma. Jpn J Ophthalmol 50:557-569, 2006
8)Cimino L, Chan CC, Shen DF et al:Ocular involvement in nasal natural killer T-cell lymphoma. Int Ophthalmol 29:275-279, 2009
9)Chen CS, Miller NR, Lane A et al:Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma. J Neuro-Ophthalmol 28:31-35, 2008
10)梶田鉄平・西信良嗣・大黒伸行・他:特異な虹彩炎症状を呈したNatural Killer(NK)/T細胞リンパ腫の1例.眼紀 57:704-707,2006
11)中西頼子・宮本和明・菊池雅史・他:脈絡膜病変を呈さない転移性虹彩悪性リンパ腫(natural killer細胞型)の1例.日眼会誌 107:273-278,2003
12)Velez G, Smet MD, Whitcup SM et al:Iris involvement in primary intraocular lymphoma:report of two cases and review of the literature. Surv Ophthalmol 44:518-526, 2000
13)Woog JJ, Kim YD, Yeatts RP et al:Natural killer/T-cell lymphoma with ocular and adnexal involvement. Ophthalmology 113:140-147, 2006
14)Aozasa K, Takakuwa T, Hongyo T et al:Nasal NK/T-cell lymphoma:epidemiology and pathogenesis. Int J Hematol 87:110-117, 2008
15)Hatta C, Ogasawara H, Okita J et al:Non-Hodgkin's malignant lymphoma of the sinonasal tract-treatment outcome for 53 patients according to REAL classification. Auris Nasus Larynx 28:55-60, 2001
16)Lee J, Kim WS, Park YH et al:Nasal-type NK/T cell lymphoma:clinical features and treatment outcome. Br J Cancer 92:1226-1230, 2005
17)Yong W, Zheng W, Zhu J et al:L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type. Ann Hematol 88:647-652, 2009
18)Yamaguchi M, Suzuki R, Kwong YL et al:Phase Ⅰ study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide(SMILE)chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer(NK)/T-cell lymphoma and leukemia. Cancer Sci 99:1016-1020, 2008
19)Sakata K, Fuwa N, Kodaira T et al:Analyses of dose-response in radiotherapy for patients with mature T/NK-cell lymphoma according to the WHO classification. Radiotherapy and Oncology 79:179-184, 2006